Saegis Pharmaceuticals' Acquisition

Saegis Pharmaceuticals was acquired by H. Lundbeck on December 20, 2006.

Saegis Pharmaceuticals is a leader in the development of next generation medicines to improve memory and cognition deficits associated with human Central Nervous System (CNS) diseases. As the first co…

Articles about Saegis Pharmaceuticals' Acquisition: